Copyright
©The Author(s) 2017.
World J Gastroenterol. Feb 28, 2017; 23(8): 1489-1496
Published online Feb 28, 2017. doi: 10.3748/wjg.v23.i8.1489
Published online Feb 28, 2017. doi: 10.3748/wjg.v23.i8.1489
Table 2 Factors affecting the clinical activity of Crohn’s disease: Results of logistic regression analysis of each factor
| IFX-TL (μg/mL) | ATI levels (AU/mL) | |
| Overall predictability (%) | 82.0 | 75.9 |
| Quiescent group (%) | 82.9 | 96.3 |
| Active group (%) | 80.4 | 43.1 |
| P value | < 0.001 | 0.003 |
| Odds ratio (95%CI) | 0.103 (0.045-0.236) | 1.055 (1.018-1.093) |
- Citation: Oh EH, Ko DH, Seo H, Chang K, Kim GU, Song EM, Seo M, Lee HS, Hwang SW, Yang DH, Ye BD, Byeon JS, Myung SJ, Yang SK, Park SH. Clinical correlations of infliximab trough levels and antibodies to infliximab in South Korean patients with Crohn’s disease. World J Gastroenterol 2017; 23(8): 1489-1496
- URL: https://www.wjgnet.com/1007-9327/full/v23/i8/1489.htm
- DOI: https://dx.doi.org/10.3748/wjg.v23.i8.1489